
Suven Pharmaceuticals Outperforms Sector with Notable Stock Gains and Long-Term Growth
2025-04-03 09:35:30Suven Pharmaceuticals has experienced notable stock performance, rising significantly on April 3, 2025, and outperforming its sector. The company has shown resilience over various time frames, achieving a substantial increase over the past year and an impressive long-term growth rate compared to the broader market.
Read More
Suven Pharmaceuticals Shows Mixed Performance Amid Broader Market Gains
2025-04-02 11:20:23Suven Pharmaceuticals experienced notable trading activity, gaining 3.17% on April 2, 2025, and reaching an intraday high of Rs 1111.55. While the stock has shown mixed short-term performance, it has significantly outperformed the Sensex over the past year, which has seen modest gains.
Read More
Suven Pharmaceuticals Faces Decline Amid Broader Market Challenges and Mixed Momentum Signals
2025-04-01 11:50:27Suven Pharmaceuticals saw a decline on April 1, 2025, underperforming its sector. The stock reached an intraday low, remaining above its 200-day moving average but below several shorter-term averages. In the broader market, the Sensex also faced challenges, reflecting mixed signals in market momentum.
Read More
Suven Pharmaceuticals Shows Resilience Amid Broader Market Fluctuations
2025-03-28 11:20:25Suven Pharmaceuticals experienced significant trading activity, rebounding from an initial decline to reach an intraday high. While the stock has faced recent weekly and monthly declines, it has outperformed the broader market over the past year, showcasing resilience amid fluctuating market conditions.
Read More
Suven Pharmaceuticals Faces Mixed Performance Amid Broader Market Resilience
2025-03-27 09:40:27Suven Pharmaceuticals saw a decline on March 27, 2025, underperforming the broader sector. The stock's performance is mixed, positioned above its 200-day moving average but below shorter-term averages. Despite recent setbacks, it has shown significant growth over the past year and five years compared to the Sensex.
Read More
Suven Pharmaceuticals Faces Continued Decline Amid Broader Market Gains
2025-03-26 10:20:25Suven Pharmaceuticals has faced a decline over the past three days, with an overall drop of 8.75%. The stock has underperformed relative to the broader sector and the Sensex in the short term, despite showing significant annual growth. Current moving averages indicate mixed short-term performance.
Read More
Suven Pharmaceuticals Faces Volatility Amidst Mixed Performance Metrics and Sector Underperformance
2025-03-25 11:45:45Suven Pharmaceuticals has faced a decline of 5.57% over two days, despite an initial gain on March 25, 2025. The stock has underperformed its sector recently, with a monthly decrease of 5.71%. However, it has shown significant long-term growth, increasing 75.17% over the past year.
Read More
Suven Pharmaceuticals Exhibits Strong Performance Amid Broader Market Gains
2025-03-20 11:35:24Suven Pharmaceuticals has experienced significant stock performance, outperforming its sector and showing a consistent upward trend over the past three days. The stock is trading above all major moving averages, reflecting strong performance metrics, including substantial gains over the past year and five years compared to the broader market.
Read More
Suven Pharmaceuticals Shows Strong Performance Amid Broader Market Gains
2025-03-19 15:35:29Suven Pharmaceuticals has experienced significant trading activity, showing a positive trend with a cumulative return over the past two days. The stock is currently positioned above several moving averages, indicating mixed short-term performance. Over the past year, it has notably outperformed the broader market.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Apr-2025 | Source : BSECompliance Certificate under Regulation 74(5) of SEBI (DP) Regulations
Cautionary Email Received From The Stock Exchange
02-Apr-2025 | Source : BSECautionary email received from the stock exchange
Announcement under Regulation 30 (LODR)-Change in Management
28-Mar-2025 | Source : BSEResignation of Senior Management Personnel
Corporate Actions
28 May 2025
Suven Pharmaceuticals Ltd has declared 100% dividend, ex-date: 09 Sep 22
No Splits history available
Suven Pharmaceuticals Ltd has announced 1:1 bonus issue, ex-date: 25 Sep 20
No Rights history available